These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 35836115

  • 1. Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan.
    Hamazaki M, Sawada T, Yamamura T, Maeda K, Mizutani Y, Ishikawa E, Furune S, Yamamoto K, Ishikawa T, Kakushima N, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Nakamura M, Fujishiro M.
    BMC Gastroenterol; 2022 Jul 14; 22(1):342. PubMed ID: 35836115
    [Abstract] [Full Text] [Related]

  • 2. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
    Mizuno S, Masaoka T, Naganuma M, Kishimoto T, Kitazawa M, Kurokawa S, Nakashima M, Takeshita K, Suda W, Mimura M, Hattori M, Kanai T.
    Digestion; 2017 Jul 14; 96(1):29-38. PubMed ID: 28628918
    [Abstract] [Full Text] [Related]

  • 3. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
    Cruz-Aguliar RM, Wantia N, Clavel T, Vehreschild MJGT, Buch T, Bajbouj M, Haller D, Busch D, Schmid RM, Stein-Thoeringer CK.
    Digestion; 2019 Jul 14; 100(2):127-138. PubMed ID: 30423561
    [Abstract] [Full Text] [Related]

  • 4. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T, Hausken T, Hov JR, Valeur J, Sangnes DA, El-Salhy M, Gilja OH, Hatlebakk JG, Lied GA.
    Scand J Gastroenterol; 2019 Jun 14; 54(6):690-699. PubMed ID: 31190584
    [Abstract] [Full Text] [Related]

  • 5. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
    Lin H, Guo Q, Wen Z, Tan S, Chen J, Lin L, Chen P, He J, Wen J, Chen Y.
    Microb Cell Fact; 2021 Dec 28; 20(1):233. PubMed ID: 34963452
    [Abstract] [Full Text] [Related]

  • 6. The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms.
    El-Salhy M, Mazzawi T, Hausken T, Hatlebakk JG.
    Scand J Gastroenterol; 2022 Sep 28; 57(9):1036-1045. PubMed ID: 35486073
    [Abstract] [Full Text] [Related]

  • 7. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
    Huang HL, Chen HT, Luo QL, Xu HM, He J, Li YQ, Zhou YL, Yao F, Nie YQ, Zhou YJ.
    J Dig Dis; 2019 Aug 28; 20(8):401-408. PubMed ID: 31070838
    [Abstract] [Full Text] [Related]

  • 8. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
    Mazzawi T, Lied GA, Sangnes DA, El-Salhy M, Hov JR, Gilja OH, Hatlebakk JG, Hausken T.
    PLoS One; 2018 Aug 28; 13(11):e0194904. PubMed ID: 30427836
    [Abstract] [Full Text] [Related]

  • 9. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
    Holvoet T, Joossens M, Vázquez-Castellanos JF, Christiaens E, Heyerick L, Boelens J, Verhasselt B, van Vlierberghe H, De Vos M, Raes J, De Looze D.
    Gastroenterology; 2021 Jan 28; 160(1):145-157.e8. PubMed ID: 32681922
    [Abstract] [Full Text] [Related]

  • 10. Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms.
    Browne PD, Cold F, Petersen AM, Halkjær SI, Christensen AH, Günther S, Hestbjerg Hansen L.
    Gut Microbes; 2021 Jan 28; 13(1):1-16. PubMed ID: 34074214
    [Abstract] [Full Text] [Related]

  • 11. Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation.
    El-Salhy M, Mazzawi T, Hausken T, Hatlebakk JG.
    Neurogastroenterol Motil; 2022 Sep 28; 34(9):e14353. PubMed ID: 35302268
    [Abstract] [Full Text] [Related]

  • 12. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome.
    Lahtinen P, Jalanka J, Hartikainen A, Mattila E, Hillilä M, Punkkinen J, Koskenpato J, Anttila VJ, Tillonen J, Satokari R, Arkkila P.
    Aliment Pharmacol Ther; 2020 Jun 28; 51(12):1321-1331. PubMed ID: 32343000
    [Abstract] [Full Text] [Related]

  • 13. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome.
    El-Salhy M, Casen C, Valeur J, Hausken T, Hatlebakk JG.
    World J Gastroenterol; 2021 May 14; 27(18):2219-2237. PubMed ID: 34025075
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Mazzawi T, El-Salhy M, Lied GA, Hausken T.
    Front Cell Infect Microbiol; 2021 May 14; 11():524851. PubMed ID: 34055657
    [Abstract] [Full Text] [Related]

  • 17. Fecal microbiota transplantation influences microbiota without connection to symptom relief in irritable bowel syndrome patients.
    Hartikainen AK, Jalanka J, Lahtinen P, Ponsero AJ, Mertsalmi T, Finnegan L, Crispie F, Cotter PD, Arkkila P, Satokari R.
    NPJ Biofilms Microbiomes; 2024 Aug 28; 10(1):73. PubMed ID: 39191760
    [Abstract] [Full Text] [Related]

  • 18. The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study.
    Holster S, Lindqvist CM, Repsilber D, Salonen A, de Vos WM, König J, Brummer RJ.
    Clin Transl Gastroenterol; 2019 Apr 28; 10(4):e00034. PubMed ID: 31009405
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
    Aroniadis OC, Brandt LJ, Oneto C, Feuerstadt P, Sherman A, Wolkoff AW, Kassam Z, Sadovsky RG, Elliott RJ, Budree S, Kim M, Keller MJ.
    Lancet Gastroenterol Hepatol; 2019 Sep 28; 4(9):675-685. PubMed ID: 31326345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.